Recap: Biomarin Pharmaceutical Q3 Earnings
Biomarin Pharmaceutical (NASDAQ:BMRN) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:00 PM.
Here's what investors need to…
75,620€
-6,34%
Echtzeit-Aktienkurs Biomarin Pharmaceutical Inc.
Bid:
Ask:
Nachrichten zur Biomarin Pharmaceutical Inc. Aktie
Biomarin Pharmaceutical Inc. Q3 Loss decreases, but misses estimates
WASHINGTON (dpa-AFX) - Biomarin Pharmaceutical Inc. (BMRN) released Loss for third quarter that decreased from last year but missed the…
Form 8-K BIOMARIN PHARMACEUTICAL For: Oct 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Can BioMarin (BMRN) Keep the Earnings Surprise Streak Alive?
BioMarin (BMRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Insiderhandel: Chief Executive Officer verkauft Aktien von Biomarin Pharmaceutical im Wert von 359.560$
Bienaime, Jean Jacques - Vorstand - Tag der Transaktion: 2022-10-14...…
Expert Ratings for Biomarin Pharmaceutical
Analysts have provided the following ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) within the last quarter:
Latest Ratings for BMRN
…
BioMarin (BMRN) Hemophilia Gene Therapy BLA Gets FDA Acceptance
If approved, BioMarins (BMRN) valoctocogene roxaparvovec will become the first gene therapy for treating hemophilia A in the United States.…
BioMarin Says FDA Accepts BLA for Hemophilia A Therapy
BioMarin Says FDA Accepts BLA for Hemophilia A Therapy...…
FDA accepts BioMarin BLA for hemophilia A gene therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
BioMarin (BMRN) Starts Restructuring Moves to Increase Efficiency
BioMarin (BMRN) intends to reduce the existing workforce by nearly 4%. The company plans to use the savings in costs…
Form 8-K BIOMARIN PHARMACEUTICAL For: Oct 06
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
BioMarin redesigns organization, will lay off about 4% of its workforce
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
BioMarin Reduces About 4% Of Global Workforce
WASHINGTON (dpa-AFX) - BioMarin Pharmaceutical Inc. (BMRN) announced a reduction of about 120 employees, or roughly four percent of the…
BioMarin Simplifies Organizational Structure to Increase Efficiency
SAN RAFAEL, Calif., Oct. 6, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced its decision to redesign the organization…
BioMarin to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, October 26, at 4:30pm ET
SAN RAFAEL, Calif., Oct. 4, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and…
BioMarin Pharmaceutical: Neues Kursziel
St. Louis (www.aktiencheck.de) - Rating-Update:
Paul Matteis, Analyst von Stifel, stuft die Aktie von BioMarin Pharmaceutical Inc. (ISIN: US09061G1013, WKN…